Cargando…
P493: ORAL-ATO/ATRA/ASCORBIC ACID (AAA)-BASED INDUCTION OR MAINTENANCE OF FIRST COMPLETE REMISSION IMPROVED OUTCOMES IN NEWLY DIAGNOSED APL: A MULTICENTRE ANALYSIS OF THE APL ASIAN CONSORTIUM (APLAC)
Autores principales: | Gill, Harry, Raghupathy, Radha, Hou, Hsin-An, Tantiworawit, Adisak, Ooi, Melissa G., Chia, Priscella S., Gin Gan, Gin, Wong, Chieh-Lee, Chin, Lynn, Yim, Rita, Lee, Paul, Au, Lester, LI, Vivian, Kit Garret Leung, Man, Joo Chng, Wee, Chien Chou, Wen, Tien, Hwei-Fang, Kumana, Cyrus, Lam Kwong, Yok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429292/ http://dx.doi.org/10.1097/01.HS9.0000968880.61591.96 |
Ejemplares similares
-
S133: AN ENTIRELY ORAL REGIMEN OF ORAL-ATO, ATRA AND ASCORBIC ACID IN RISK-ADAPTED TREATMENT OF NEWLY-DIAGNOSED APL RESULTED IN EXCELLENT CLINICAL/MOLECULAR RESPONSES WITH DURABLE REMISSION
por: Gill, Harry, et al.
Publicado: (2023) -
UK Experience of an Alternative ATO Dosing Regimen in APL
por: Russell, Nigel, et al.
Publicado: (2020) -
APL Congress
por: Gjerløv, Per, et al.
Publicado: (1973) -
APL : a short course
por: Pakin, Sandra
Publicado: (1973) -
APL2 in depth
por: Thomson, Norman D, et al.
Publicado: (1995)